InfuSystem Holdings, Inc. (NYSE:INFU) Shares Purchased by Bank of New York Mellon Corp

Bank of New York Mellon Corp boosted its stake in shares of InfuSystem Holdings, Inc. (NYSE:INFU) by 6.1% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 93,899 shares of the company’s stock after acquiring an additional 5,391 shares during the quarter. Bank of New York Mellon Corp owned about 0.44% of InfuSystem worth $641,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently modified their holdings of INFU. Vanguard Group Inc. grew its holdings in InfuSystem by 1.7% during the first quarter. Vanguard Group Inc. now owns 1,083,730 shares of the company’s stock worth $9,288,000 after acquiring an additional 18,432 shares during the period. Sequoia Financial Advisors LLC purchased a new stake in InfuSystem during the second quarter worth about $272,000. Wasatch Advisors LP grew its position in InfuSystem by 3.4% during the fourth quarter. Wasatch Advisors LP now owns 846,609 shares of the company’s stock worth $8,923,000 after buying an additional 27,881 shares during the period. Ranger Investment Management L.P. increased its holdings in InfuSystem by 4.7% in the fourth quarter. Ranger Investment Management L.P. now owns 689,842 shares of the company’s stock valued at $7,271,000 after buying an additional 30,835 shares in the last quarter. Finally, First Eagle Investment Management LLC lifted its position in shares of InfuSystem by 12.7% during the 1st quarter. First Eagle Investment Management LLC now owns 605,235 shares of the company’s stock valued at $5,187,000 after acquiring an additional 68,021 shares during the period. 71.13% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised InfuSystem from a “buy” rating to a “strong-buy” rating in a research note on Friday.

InfuSystem Trading Down 7.6 %

InfuSystem stock opened at $5.97 on Tuesday. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.64 and a current ratio of 2.07. InfuSystem Holdings, Inc. has a 52 week low of $5.74 and a 52 week high of $10.99. The stock has a market capitalization of $127.13 million, a P/E ratio of -597,000.00 and a beta of 1.46.

InfuSystem (NYSE:INFU) last posted its quarterly earnings data on Thursday, August 8th. The company reported $0.03 EPS for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). The company had revenue of $33.70 million for the quarter. InfuSystem had a net margin of 0.28% and a return on equity of 0.70%.

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.